Westpac Banking Corp appoints deputy CEO

Is this a sign of long-serving Gail Kelly's impending departure?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Westpac Banking Corp (ASX: WBC) has promoted chief financial officer Phil Coffey to a newly-created role of deputy chief executive officer where he will work with the long-serving Gail Kelly on "critical strategic issues".

While the move is certain to spark speculation that Kelly is on her way out after six years in the job (12 years if you include her time at St George Bank), it seems more likely that it is simply a continuation of the reshuffle amongst the top executive rankings which saw chief information officer Clive Whincup move into an innovation role in January.

Coffey is highly respected within the bank and played a key role in guiding the company through the depths of the GFC, helping the bank to build one of the strongest balance sheets in Australian banking. Despite this, analysts expect that when Kelly does move on from the bank (which could be within the next two years), it will be the boss of the bank's Australian division, Brian Hartzer, or institutional boss Rob Whitfield that will take the top job.

Kelly led Westpac to a record $6.82 billion profit for the year ending 31 September 2013, while Commonwealth Bank of Australia (ASX: CBA), Australia and New Zealand Banking Group (ASX: ANZ) and National Australia Bank Ltd (ASX: NAB) also achieved strong results. Combined, the big four posted an annual profit of $27.3 billion.

Foolish takeaway

Shares in Australia's major banks have recorded incredible gains over the last 18 months, as investors have sought out high-yielding stocks to offset low bond yields and poor returns from term deposits. Although they are likely to record even greater profits this year than they did in 2013, thanks to low borrowing costs and low bad debts, they do not represent a good buy at today's prices.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »